South Africa: Patients in South Africa to Access Six-Month, All-Oral Treatment for Highly Drug-Resistant Tuberculosis

[TB Alliance] TB Alliance welcomes the Wits Health Consortium and the South African National Department of Health (DoH)'s announcement of an initiative to provide a new, shorter treatment regimen for people affected with highly drug-resistant forms of tuberculosis (TB). Funded by the United States Agency for International Development, a new clinical access program (CAP) will enroll 400 people in South Africa for treatment with a three-drug, six-month, all-oral regimen of bedaquiline, pretomanid and linezolid (know
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news